Following twenty years of scientific research and eighteen months of strategic planning, Micregen was founded in 2015. The proven team of leading business development, biotech industry and stem cell experts are focusing their research on the use of various stem cell types to develop several novel stem cell secretome therapeutics, collectively referred to as Secretomix®. Micregen’s innovative approach and cutting-edge Secretomix® products aim to change how multiple age-related critical and chronic conditions are managed.
History of Micregen
Get in touch with us